Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 52
- Q4 2025, −16 vs. previous quarter
- 13F value
- $5.93M
- Reported value at the end of Q4 2025
- Superinvestors holding
- 0
- At the end of Q4 2025
Superinvestors holding APLT, Q4 2025
No superinvestor reported holding APLT at the end of Q4 2025.
Latest insider trades
Open-market purchases and sales by Applied Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)3:13 PM ET | Dec 16 | 2 days | Kanter Stacy J.Director | SSale | −43.0K | $0.112 | −$4.82K | −39.8%65.0K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −10.4K | $0.44 | −$4.56K | −1.2%890.4K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Funtleyder Leslie D.See Remarks | SSale | −14.5K | $0.44 | −$6.38K | −3.6%390.5K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Chinoporos ConstantineSee Remarks | SSale | −447 | $0.44 | −$196.68 | −0.2%271.4K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Funtleyder Leslie D.See Remarks | SSale | −22.9K | $0.61 | −$14.0K | −5.4%405.0K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | −86.1K | $0.61 | −$52.5K | −8.7%900.8K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Chinoporos ConstantineSee Remarks | SSale | −28.1K | $0.61 | −$17.2K | −9.4%271.9K after | |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Funtleyder Leslie D.Chief Financial Officer | SSale | −13.5K | $5.83 | −$78.9K | −4.6%277.9K after | |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | −22.7K | $5.83 | −$132.2K | −2.2%986.9K after | |
| Aug 14, 2024 (view filing) | Aug 12-14 | 2 days | Shendelman ShoshanaPresident and CEO | SSale | −777.0K | $6.06 | −$4.71M | −14.2%4.69M after | 3 lots |
Top 10 13F holders, Q4 2025
The largest institutional positions in Applied Therapeutics, Inc. at the end of Q4 2025; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 21,747,844 | $2.17M | 0.00% | +344,544+1.6% | Added |
| Vanguard Group Inc | 6,353,018 | $635.3K | 0.00% | +1,250,329+24.5% | Added |
| Knoll Capital Management, LLC | 6,050,000 | $605.0K | 0.28% | −1,749,687−22.4% | Reduced |
| Deltec Asset Management LLC | 3,847,449 | $384.7K | 0.06% | +3,847,449 | New |
| BlackRock, Inc. | 3,251,462 | $325.1K | 0.00% | −592,271−15.4% | Reduced |
| Pathstone Holdings, LLC | 2,643,540 | $305.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,706,156 | $270.6K | 0.00% | +2,706,156 | New |
| Jane Street Group, LLC | 2,087,404 | $208.7K | 0.00% | +2,087,404 | New |
| Geode Capital Management, LLC | 1,492,903 | $149.3K | 0.00% | +214,747+16.8% | Added |
| Adage Capital Partners GP, L.L.C. | 1,211,629 | $121.2K | 0.00% | −1,000,000−45.2% | Reduced |